Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel rejects expanded use of Amarin's Vascepa amid questions for fish oil drug
FDA panel rejects expanded use of Amarin's Vascepa amid questions for fish oil drug
FDA panel rejects expanded use of Amarin's Vascepa amid questions for fish oil drug
Submitted by
admin
on October 16, 2013 - 3:40pm
Source:
Yahoo/AP
News Tags:
Amarin
FDA
advisory panels
Vascepa
Headline:
FDA panel rejects expanded use of Amarin's Vascepa amid questions for fish oil drug
Do Not Allow Advertisers to Use My Personal information
